|
Cash Flow for
Pain Therapeutics
(PTIE)
|
|
|
|
|
|
|
| Cash Flow |
in Thousands of Dollars |
|
|
| Net Income |
(3,446) |
(2,613) |
(12,023) |
(3,467) |
15,347 |
| Depreciation |
122 |
163 |
232 |
257 |
452 |
| Amortization |
- |
- |
- |
- |
- |
| Amortization of Intagibles |
- |
- |
- |
- |
- |
| Deferred Income Taxes |
N/A |
- |
- |
- |
- |
| Operating Gains/Losses |
- |
- |
- |
- |
381 |
| Extraordinary Gains/Losses |
- |
- |
- |
- |
- |
| Decrease in Receivables |
- |
7,114 |
(4,812) |
(2,104) |
- |
| Decrease in Inventories |
- |
- |
- |
- |
- |
| Decrease in Prepaid Expenses |
- |
- |
- |
- |
- |
| Decrease in Other Current Assets |
105 |
(214) |
266 |
132 |
(238) |
| Increase in Payables |
(103) |
(643) |
(210) |
(899) |
(1,408) |
| Increase in Other Current Liabilities |
(105) |
(152) |
(779) |
(700) |
212 |
| Decrease in Other Working Capital |
(55) |
413 |
6,295 |
(243) |
(14,861) |
| Other Non-Cash Items |
(3,689) |
(4,328) |
10,888 |
(7,667) |
11,278 |
| Net Cash from Continuing Operations |
(7,171) |
(260) |
(143) |
(14,691) |
11,163 |
| Net Cash from Discontinued Operations |
- |
- |
- |
- |
- |
| Cash from Operating Activities |
(7,171) |
(260) |
(143) |
(14,691) |
11,163 |
|
|
| Sale of Property, Plant, Equipment |
- |
- |
- |
- |
- |
| Sale of Long Term Investments |
- |
- |
- |
- |
- |
| Sale of Short Term Investments |
- |
62,400 |
118,216 |
50,772 |
82,358 |
| Purchase of Property, Plant, Equipment |
- |
- |
- |
- |
(2,122) |
| Acquisitions |
- |
- |
- |
- |
- |
| Purchase of Long Term Investments |
- |
- |
- |
- |
- |
| Purchase of Short Term Investments |
(20,768) |
(2,497) |
(65,753) |
(154,000) |
- |
| Other Investment Changes, Net |
- |
- |
- |
- |
- |
| Cash from Investing Activities |
17,622 |
59,903 |
52,463 |
(103,228) |
80,236 |
| Cash from Discontinued Investing Activities |
- |
- |
- |
- |
- |
|
| Issuance of Debt |
- |
- |
- |
- |
- |
| Issuance of Capital Stock |
- |
9,042 |
2,085 |
564 |
1,101 |
| Repayment of Debt |
- |
- |
- |
- |
- |
| Repurchase of Capital Stock |
- |
- |
- |
- |
(26,207) |
| Payment of Cash Dividends |
(33,995) |
- |
- |
- |
- |
| Other Financing Charges, Net |
(245) |
(339) |
(85,401) |
(9) |
298 |
| Cash from Financing Activities |
(34,240) |
8,703 |
(83,316) |
555 |
(24,808) |
| Cash from Discontinued Financing Activities |
- |
- |
- |
- |
- |
|
|
| Effect of Exchange Rate Changes |
- |
- |
- |
- |
- |
| Net Change in Cash |
(23,789) |
68,346 |
(30,996) |
(117,364) |
66,591 |
|
| Cash at Beginning of Year |
73,144 |
4,798 |
35,794 |
153,158 |
86,567 |
| Cash at End of Period |
49,355 |
73,144 |
4,798 |
35,794 |
153,158 |
| Foreign Sales |
- |
- |
- |
- |
N/A |
| Domestic Sales |
- |
- |
- |
- |
N/A |
|
|
|
